GCC pharma regulations in 2026 emphasize eCTD v4.0 adoption, harmonization, real-world evidence, and strict Saudi/UAE rules. Strategic compliance and local QPPV roles are key for market access.
GCC 2026 Regulatory Trends Shaping Pharma and Biotech Read More »
Middle East and GCC pharma regulations are rapidly evolving with digital submissions, stricter pharmacovigilance, biotech scrutiny, and tougher device registration, requiring strategic compliance and local expertise.
7 Emerging Trends in Middle Eastern and GCC Pharma Regulations to Watch Now Read More »
Digital regulatory intelligence streamlines Middle East market entry by providing real-time compliance updates, centralized data, and regulatory guidance, enhancing efficiency and reducing risks across GCC countries.
Digital Regulatory Intelligence: Transforming Middle East Market Entry Read More »
